Cerus (CERS) Cash & Current Investments (2010 - 2026)
Cerus' (CERS) quarterly Cash & Current Investments came in at $56.3 million in Q2 2026, down 27.89% year-over-year from $78.0 million in Q2 2025, and down 30.04% quarter-over-quarter from $80.4 million in Q1 2026.
Analysis
Cerus (CERS) Cash & Current Investments (2010 - 2026) Analysis & Trends
Cerus has disclosed Cash & Current Investments across 17 years of filings, most recently posting $56.3 million for Q2 2026.
- In Q2 2026, Cash & Current Investments fell 27.89% year-over-year to $56.3 million; the TTM figure through Jun 2026 stood at $56.3 million (down 27.89% YoY), while the FY2025 annual figure was $82.9 million, up 3.02% from the prior year.
- Cash & Current Investments came in at $56.3 million for Q2 2026 at Cerus, down from $80.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $108.6 million in Q1 2022 to a low of $56.3 million in Q2 2026.
- Average Cash & Current Investments over 5 years is $83.4 million, with a median of $80.4 million recorded in 2024.
- Year-over-year, Cash & Current Investments plunged 35.54% in 2023 and climbed 22.17% in 2024.
- Over 5 years, Cash & Current Investments stood at $102.2 million in 2022, then sank by 35.54% to $65.9 million in 2023, then grew by 22.17% to $80.5 million in 2024, then climbed by 3.02% to $82.9 million in 2025, then slumped by 32.11% to $56.3 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $56.3 million in Q2 2026, $80.4 million in Q1 2026, and $82.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | 56.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.26 Mn |
| Mar 31, 2026 | 80.43 Mn |
| Dec 31, 2025 | 82.88 Mn |
| Sep 30, 2025 | 78.51 Mn |
| Jun 30, 2025 | 78.03 Mn |
| Mar 31, 2025 | 80.92 Mn |
| Dec 31, 2024 | 80.45 Mn |
| Sep 30, 2024 | 75.57 Mn |
| Jun 30, 2024 | 71.19 Mn |
| Mar 31, 2024 | 72.18 Mn |
| Dec 31, 2023 | 65.85 Mn |
| Sep 30, 2023 | 79.01 Mn |
| Jun 30, 2023 | 84.50 Mn |
| Mar 31, 2023 | 94.68 Mn |
| Dec 31, 2022 | 102.15 Mn |
| Sep 30, 2022 | 103.83 Mn |
| Jun 30, 2022 | 107.05 Mn |
| Mar 31, 2022 | 108.56 Mn |
| Dec 31, 2021 | 129.36 Mn |
| Sep 30, 2021 | 119.96 Mn |